Pellegrino, Raffaello
Paganelli, Roberto
Di Iorio, Angelo
Bandinelli, Stefania
Moretti, Antimo
Iolascon, Giovanni
Sparvieri, Eleonora
Tarantino, Domiziano
Ferrucci, Luigi
Funding for this research was provided by:
Ministero della Salute (ICS 110.1/RS97.71, ICS 110.1/RS97.71)
U.S. National Institute on Aging (N01-AG-916413)
Article History
Received: 6 May 2023
Accepted: 16 August 2023
First Online: 4 September 2023
Declarations
:
: The InCHIANTI study baseline was approved by the Ethical committee at INRCA, Ancona (protocol 14/CE, 28 February 2000) as the FU1 (protocol 45/01, 16 January 2001). InCHIANTI study FU2 and FU3 were approved by the Local Ethical Committee at Azienda Sanitaria Firenze (protocol n◦ 5/04, 12 May 2004) The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of INRCA di Ancona (Italy). Clinical Trial Registration: NCT01331512.
: Written informed consent was obtained from the patients to participate at the Study.
: Roberto Paganelli and Luigi Ferrucci are members of the Editorial board of the Journal.